A Study of MHB039A for Advanced Solid Tumor
Clinical trial NCT06345482 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06345482
- Sponsor
- Minghui Pharmaceutical (Hangzhou) Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2028-04-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.